A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19

Autor: Seethamraju, Harish, Yang, Otto O., Loftus, Richard, Ogbuagu, Onyema, Sammartino, Daniel, Mansour, Ali, Sacha, Jonah B., Ojha, Sohita, Hansen, Scott G., Arman, Arvin Cyrus, Lalezari, Jacob P.

Publikováno v: In Clinical Therapeutics November 2024 46(11):891-899

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Functional genomic analysis of the 68-1 RhCMV-Mycobacteria tuberculosis vaccine reveals an IL-15 response signature that is conserved with vector attenuation.

Autor: Cheng-Jung Sung, Whitmore, Leanne S., Smith, Elise, Chang, Jean, Tisoncik-Go, Jennifer, Barber-Axthelm, Aaron, Selseth, Andrea, Feltham, Shana, Ojha, Sohita, Hansen, Scott G., Picker, Louis J., Gale Jr., Michael

Publikováno v: Frontiers in Immunology; 2024, p1-14, 14p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Functional genomic analysis of the 68-1 RhCMV- Mycobacteria tuberculosis vaccine reveals an IL-15 response signature that is conserved with vector attenuation.

Autor: Sung CJ; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, United States., Whitmore LS; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, United States., Smith E; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, United States., Chang J; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, United States., Tisoncik-Go J; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, Seattle, WA, United States., Barber-Axthelm A; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States., Selseth A; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States., Feltham S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States., Ojha S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States., Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States., Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, United States., Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, Seattle, WA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Oct 15; Vol. 15, pp. 1460344. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024).